Want to see TSE:CWEB full AI Analyst Report?
CWEB Stock Chart & Stats
C$0.42
C$0.03(7.46%)
At close: 4:00 PM EDT
C$0.42
C$0.03(7.46%)
Day’s Range― - ―
52-Week RangeC$0.11 - C$1.33
Previous CloseN/A
Volume12.59K
Average Volume (3M)74.18K
Market Cap
C$120.72M
Enterprise ValueC$86.09
Total Cash (Recent Filing)C$13.97M
Total Debt (Recent Filing)C$13.03M
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Nov 16, 2026EPS Estimate
-0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding271,291,530
10 Day Avg. Volume43,382
30 Day Avg. Volume74,181
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-28.04
Price to Sales (P/S)1.15
P/FCF Ratio-3.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.15
Revenue Forecast (FY)C$47.90M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageThe relatively low debt burden reduces near-term balance-sheet pressure and leaves more flexibility to manage operations while pursuing recovery. Compared with a highly leveraged structure, manageable obligations may help the company withstand continued losses without immediate debt-related constraints.
Broad Product And Sales ChannelsA broad portfolio across ingestibles, topicals and pet products gives the company several avenues to address wellness demand rather than relying on one formulation. Combining e-commerce with wholesale distribution also supports multiple routes to customers and retailers.
Less Severe Losses Than Prior PeriodsAlthough the company remains deeply unprofitable, less severe losses than in the 2022–2024 period indicate some progress in reducing the scale of deterioration. If sustained, that improvement could support a gradual path toward better operating discipline and eventual break-even.
Bears Say
Declining RevenueFalling revenue weakens operating leverage and makes it harder to absorb fixed corporate, marketing and distribution costs. The multi-year shrinkage described in the pack suggests the challenge is structural enough to remain relevant over coming quarters, not merely a single reporting-period fluctuation.
Deep Operating And Net LossesLarge operating and net losses show that gross profit is not sufficient to cover the company’s broader cost base. Continued losses can consume financial resources, limit reinvestment capacity and make sustainable profitability dependent on a material improvement in revenue or cost efficiency.
Persistent Negative Cash FlowPersistent cash consumption means the business is not currently funding operations internally, while worsening free cash flow indicates that self-funding is not yet improving. This can restrict strategic flexibility and increase dependence on available liquidity or future financing to support operations.
Charlotte's Web Holdings News
CWEB FAQ
What was Charlotte's Web Holdings’s price range in the past 12 months?
Charlotte's Web Holdings lowest stock price was C$0.10 and its highest was C$1.33 in the past 12 months.
What is Charlotte's Web Holdings’s market cap?
Charlotte's Web Holdings’s market cap is C$120.72M.
When is Charlotte's Web Holdings’s upcoming earnings report date?
Charlotte's Web Holdings’s upcoming earnings report date is Nov 16, 2026 which is in 64 days.
How were Charlotte's Web Holdings’s earnings last quarter?
Charlotte's Web Holdings released its earnings results on Aug 13, 2026. The company reported -C$0.028 earnings per share for the quarter.
Is Charlotte's Web Holdings overvalued?
According to Wall Street analysts Charlotte's Web Holdings’s price is currently Overvalued.
Does Charlotte's Web Holdings pay dividends?
Charlotte's Web Holdings does not currently pay dividends.
What is Charlotte's Web Holdings’s EPS estimate?
Charlotte's Web Holdings’s EPS estimate is -0.03.
How many shares outstanding does Charlotte's Web Holdings have?
Charlotte's Web Holdings has 271,291,530 shares outstanding.
What happened to Charlotte's Web Holdings’s price movement after its last earnings report?
Charlotte's Web Holdings reported an EPS of -C$0.028 in its last earnings report. Following the earnings report the stock price went up 3.797%.
Which hedge fund is a major shareholder of Charlotte's Web Holdings?
Currently, no hedge funds are holding shares in TSE:CWEB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Charlotte's Web Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
240.19%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress relief, immune support, and post-exercise recovery, as well as easy-to-use capsules, topical CBD creams, and lotions. They also offer specialized products for pets. These offerings are available under recognized brands including Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids, such as CBD, cannabichromene, cannabigerol, and cannabinol, alongside beneficial terpenes, flavonoids, and other hemp compounds. Distribution occurs through various channels, including brick-and-mortar retail locations, healthcare providers, and direct-to-consumer sales via their online platform. The company is committed to advancing cannabinoid research; its CW Labs science division collaborates with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 as Stanley Brothers Holdings Inc., the company rebranded to Charlotte's Web Holdings, Inc. in July 2018 and is headquartered in Denver, Colorado.